Thiopentone	thiopentone	CHEMICALS	O	OTHERS	I
pretreatment	pretreatment	O	O	O	O
for	for	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
injection	injection	O	O	O	O
pain	pain	O	DISEASE	OTHERS	I
in	in	O	O	O	O
ambulatory	ambulatory	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
study	study	O	O	O	O
investigated	investigated	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
injection	injection	O	O	O	O
pain	pain	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
undergoing	undergoing	O	O	O	O
ambulatory	ambulatory	O	O	O	O
anaesthesia	anaesthesia	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
a	a	O	O	O	O
randomized	randomized	O	O	O	O
,	,	O	O	O	O
double-blind	double-blind	O	O	O	O
trial	trial	O	O	O	O
,	,	O	O	O	O
90	90	O	O	O	O
women	women	O	O	O	O
were	were	O	O	O	O
allocated	allocated	O	O	O	O
to	to	O	O	O	O
receive	receive	O	O	O	O
one	one	O	O	O	O
of	of	O	O	O	O
three	three	O	O	O	O
treatments	treatments	O	O	O	O
prior	prior	O	O	O	O
to	to	O	O	O	O
induction	induction	O	O	O	O
of	of	O	O	O	O
anaesthesia	anaesthesia	O	O	O	O
with	with	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Patients	patients	O	O	O	O
in	in	O	O	O	O
Group	group	O	O	O	O
C	c	O	O	OTHERS	I
received	received	O	O	O	O
2	2	O	O	O	O
ml	ml	O	O	O	O
normal	normal	O	O	O	O
saline	saline	O	O	O	O
,	,	O	O	O	O
Group	group	O	O	O	O
L	l	O	O	O	O
,	,	O	O	O	O
2	2	O	O	O	O
ml	ml	O	O	O	O
,	,	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
2	2	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
40	40	O	O	O	O
mg	mg	O	O	OTHERS	I
)	)	O	O	O	O
and	and	O	O	O	O
Group	group	O	O	O	O
T	t	O	O	O	O
,	,	O	O	O	O
2	2	O	O	O	O
ml	ml	O	O	O	O
thiopentone	thiopentone	CHEMICALS	O	OTHERS	I
2.5	2.5	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
50	50	O	O	O	O
mg	mg	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

Venous	venous	O	O	O	O
discomfort	discomfort	O	O	O	O
was	was	O	O	O	O
assessed	assessed	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
visual	visual	O	O	O	O
analogue	analogue	O	O	O	O
scale	scale	O	O	O	O
(	(	O	O	O	O
VAS	vas	O	O	O	O
)	)	O	O	O	O
5	5	O	O	O	O
-	-	O	O	O	O
15	15	O	O	O	O
sec	sec	O	O	O	O
after	after	O	O	O	O
commencing	commencing	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
using	using	O	O	O	O
an	an	O	O	O	O
infusion	infusion	O	O	O	O
pump	pump	O	O	O	O
(	(	O	O	O	O
rate	rate	O	O	O	O
1000	1000	O	O	O	O
micrograms.kg-1.min-1	micrograms.kg-1.min-1	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Loss	loss	O	O	OTHERS	I
of	of	O	O	OTHERS	I
consciousness	consciousness	O	O	OTHERS	I
occurred	occurred	O	O	O	O
in	in	O	O	O	O
60	60	O	O	O	O
-	-	O	O	O	O
90	90	O	O	O	O
sec.	sec.	O	O	O	O
Visual	visual	O	O	O	O
analogue	analogue	O	O	O	O
scores	scores	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
SD	sd	O	O	OTHERS	I
)	)	O	O	O	O
during	during	O	O	O	O
induction	induction	O	O	O	O
were	were	O	O	O	O
lower	lower	O	O	O	O
in	in	O	O	O	O
Groups	groups	O	O	O	O
L	l	O	O	O	O
(	(	O	O	O	O
3.3	3.3	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
2.5	2.5	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
T	t	O	O	O	O
(	(	O	O	O	O
4.1	4.1	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
2.7	2.7	O	O	O	O
)	)	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
Group	group	O	O	O	O
C	c	O	O	OTHERS	I
(	(	O	O	O	O
5.6	5.6	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
2.3	2.3	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
P	p	O	O	OTHERS	I
=	=	O	O	O	O
0.0031	0.0031	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
venous	venous	O	O	O	O
discomfort	discomfort	O	O	O	O
was	was	O	O	O	O
lower	lower	O	O	O	O
in	in	O	O	O	O
Group	group	O	O	O	O
L	l	O	O	O	O
(	(	O	O	O	O
76.6	76.6	O	O	O	O
%	%	O	O	O	O
;	;	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
Group	group	O	O	O	O
C	c	O	O	OTHERS	I
(	(	O	O	O	O
100	100	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
different	different	O	O	O	O
from	from	O	O	O	O
Group	group	O	O	O	O
T	t	O	O	O	O
(	(	O	O	O	O
90	90	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
VAS	vas	O	O	O	O
scores	scores	O	O	O	O
for	for	O	O	O	O
recall	recall	O	O	O	O
of	of	O	O	O	O
pain	pain	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
recovery	recovery	O	O	O	O
room	room	O	O	O	O
were	were	O	O	O	O
correlated	correlated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
VAS	vas	O	O	O	O
scores	scores	O	O	O	O
during	during	O	O	O	O
induction	induction	O	O	O	O
(	(	O	O	O	O
r	r	O	O	O	O
=	=	O	O	O	O
0.7045	0.7045	O	O	O	O
;	;	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.0001	0.0001	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Recovery	recovery	O	O	O	O
room	room	O	O	O	O
discharge	discharge	O	O	O	O
times	times	O	O	O	O
were	were	O	O	O	O
similar	similar	O	O	O	O
:	:	O	O	O	O
C	c	O	O	OTHERS	I
(	(	O	O	O	O
75.9	75.9	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
19.4	19.4	O	O	O	O
min	min	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
L	l	O	O	O	O
73.6	73.6	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
21.6	21.6	O	O	O	O
min	min	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
T	t	O	O	O	O
(	(	O	O	O	O
77.1	77.1	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
18.9	18.9	O	O	O	O
min	min	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Assessing	assessing	O	O	O	O
their	their	O	O	O	O
overall	overall	O	O	O	O
satisfaction	satisfaction	O	O	O	O
,	,	O	O	O	O
89.7	89.7	O	O	O	O
%	%	O	O	O	O
would	would	O	O	O	O
choose	choose	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
anaesthesia	anaesthesia	O	O	O	O
again	again	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
conclude	conclude	O	O	O	O
that	that	O	O	O	O
lidocaine	lidocaine	CHEMICALS	O	OTHERS	I
reduces	reduces	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
and	and	O	O	O	O
severity	severity	O	O	O	O
of	of	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
injection	injection	O	O	O	O
pain	pain	O	DISEASE	OTHERS	I
in	in	O	O	O	O
ambulatory	ambulatory	O	O	O	O
patients	patients	O	O	O	O
whereas	whereas	O	O	O	O
thiopentone	thiopentone	CHEMICALS	O	OTHERS	I
only	only	O	O	O	O
reduces	reduces	O	O	O	O
its	its	O	O	O	O
severity	severity	O	O	O	O
.	.	O	O	O	O

